Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents. 2020

Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
Department of Chemistry and Physics, College of Science and Mathematics, Arkansas State University, Jonesboro, AR 72467, USA.

In this paper, synthesis and antimicrobial studies of 31 novel coumarin-substituted pyrazole derivatives are reported. Some of these compounds have shown potent activity against methicillin-resistant Staphylococcus aureus (MRSA) with minimum inhibitory concentration (MIC) as low as 3.125 µg/mL. These molecules are equally potent at inhibiting the development of MRSA biofilm and the destruction of preformed biofilm. These results are very significant as MRSA strains have emerged as one of the most menacing pathogens of humans and this bacterium is bypassing HIV in terms of fatality rate.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D055624 Methicillin-Resistant Staphylococcus aureus A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS. MRSA,Methicillin Resistant Staphylococcus aureus
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
July 2023, RSC medicinal chemistry,
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
January 2017, European journal of medicinal chemistry,
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
May 2020, Chemical & pharmaceutical bulletin,
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
March 2009, Medicinal chemistry (Shariqah (United Arab Emirates)),
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
January 2018, European journal of medicinal chemistry,
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
January 2019, Mini reviews in medicinal chemistry,
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
January 2014, Acta poloniae pharmaceutica,
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
April 2004, Bioorganic & medicinal chemistry,
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
July 2020, Molecules (Basel, Switzerland),
Rawan Alnufaie, and Hansa Raj Kc, and Nickolas Alsup, and Jedidiah Whitt, and Steven Andrew Chambers, and David Gilmore, and Mohammad A Alam
January 2022, Mini reviews in medicinal chemistry,
Copied contents to your clipboard!